Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Photogen achieves favorable preliminary results with ocular melanoma treatment

June 8, 1999

Angiogenesis inhibitor SU-5416 poised to enter phase III testing in U.S. and Europe

June 7, 1999

Immune Response's membrane-bound cytokine-containing antitumor vaccines covered by U.S. patent

June 7, 1999

Cell Pathways updates clinical status of SAANDs

June 7, 1999

Immunex and Genentech reach TRAIL/Apo2L oncology agreement

June 7, 1999

New carbazole from Kyowa Hakko effective against chemotherapy-induced thrombocytopenia

June 4, 1999

Introgen Therapeutics commences phase I trial of i.v. p53 gene therapy

June 4, 1999

Spotlight on protein farnesyltransferase inhibitors

June 4, 1999

Phase II ECOG trial of didemnin B in melanoma patients yields indeterminate results

June 4, 1999

Rigel identifies cancer- and inflammation-related gene

June 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...